🔎 Trials Near Me

首頁 › 大腸直腸癌 › 加州

加州 的 大腸直腸癌 臨床試驗

136 項針對 大腸直腸癌 的研究正在 加州 各地點尋找參與者。

加州 的城市

官方研究文本(英文)

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

  • City of Hope, Duarte
  • Hoag Memorial Hospital Presbyterian, Newport Beach
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT07544589

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
招募中歡迎健康志工
45 至 75 歲 · 所有性別 · 更新於 2026年10月5日 · NCT06995898

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

  • START Los Angeles, Los Angeles
  • Valkyrie Clinical Trials (contact for more locations), Los Angeles
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT07659795

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

  • Jennifer Moreno Department of Veterans Affairs Medical Cneter, San Diego
  • Kaiser Permanente Northern California, Walnut Creek
招募中
65 至 82 歲 · 所有性別 · 更新於 2026年10月2日 · NCT05612347

Family Communications After Genetic Testing

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
  • Marshall Cancer Center, Cameron Park
  • 還有 17 項
招募中歡迎健康志工
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT07143487

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of San Diego Moores Cancer Center, La Jolla
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
招募中1/2 期
12 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT04585750

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  • Tower Cancer Research Foundation, Beverly Hills
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Cedars-Sinai Medical Center, Los Angeles
  • 還有 1 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • 還有 20 項
招募中觀察性研究歡迎健康志工
40 至 75 歲 · 所有性別 · 更新於 2026年10月2日 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #59, Santa Barbara
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT05176483

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California Los Angeles, Los Angeles
  • University of California San Diego Moores Cancer Center, San Diego
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • The Oncology Institute of Hope and Innovation, Cerritos
  • Ellison Medical Institute, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
  • 還有 3 項
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT06324357

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 9, La Jolla
  • ALX Center 11, Santa Monica
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
  • 還有 1 項
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT05877599

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • UCSF at Berkeley Outpatient Center, Berkeley
  • Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
  • UCSD Medical Center - Encinitas, Encinitas
  • 還有 21 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07222800

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
  • USC Norris Comprehensive Cancer Center, Los Angeles
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT05482893

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

  • City of Hope National Medical Center /ID# 270255, Duarte
  • UCLA - Santa Monica /ID# 270621, Santa Monica
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT06820463

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

  • UCLA ( Site 0317), Los Angeles
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06428409

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  • CBCC Global Research, Bakersfield
  • Los Angeles Cancer Network, Glendale
  • Cancer and Blood Specialty Clinic, Los Alamitos
  • 還有 4 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06750094

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

  • City of Hope Comprehensive Cancer Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07271355

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT04981119

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

  • University of California, Los Angeles UCLA, Los Angeles
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT05379595

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06218914

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  • CBCC Global Research, Bakersfield
  • Los Angeles Cancer Network, Glendale
  • Cancer and Blood Specialty Clinic, Los Alamitos
  • 還有 4 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06662786

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  • City of Hope Cancer Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • START Los Angeles, Los Angeles
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06004245

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Precision NextGen Oncology, Beverly Hills
  • OPN Healthcare, Inc, Glendale
  • University of Southern California, Los Angeles
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月24日 · NCT06047379

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月24日 · NCT07229313

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

  • UC Irvine Health Cancer Center-Newport, Costa Mesa
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • 還有 1 項
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT06102902

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
  • Local Institution - 0317, San Francisco
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT07221357

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Los Angeles
  • Research Site, Santa Rosa
招募中2 期
18 至 130 歲 · 所有性別 · 更新於 2026年9月23日 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • City of Hope, Duarte
  • University of California, Los Angeles (UCLA), Santa Monica
  • Stanford University Medical Center, Stanford
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07213791

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • UCLA Hematology/Oncology- Santa Monica, Los Angeles
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • UC IRVINE Health, Orange
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Stanford Cancer Institute, Stanford
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT06128551

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • University of California, San Francisco (UCSF), San Francisco
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月16日 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Memorial Care Orange Coast Medical Center, Fountain Valley
  • Providence Medical Foundation, Fullerton
  • Cancer & Blood Research Center, Los Alamitos
  • 還有 1 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月15日 · NCT07284849

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  • City of Hope Comprehensive Cancer Center, Duarte
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA, Los Angeles
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月11日 · NCT04929223

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • USC/Norris Comprehensive Cancer Center, Los Angeles
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月9日 · NCT06440005

資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。